SteelPeak Wealth LLC Purchases 9,777 Shares of Aflac Incorporated (NYSE:AFL)

SteelPeak Wealth LLC lifted its position in Aflac Incorporated (NYSE:AFL - Free Report) by 39.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,592 shares of the financial services provider's stock after purchasing an additional 9,777 shares during the quarter. SteelPeak Wealth LLC's holdings in Aflac were worth $3,867,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Dimensional Fund Advisors LP lifted its holdings in shares of Aflac by 6.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider's stock worth $429,319,000 after acquiring an additional 285,576 shares during the last quarter. APG Asset Management N.V. lifted its stake in Aflac by 1.3% during the second quarter. APG Asset Management N.V. now owns 2,429,316 shares of the financial services provider's stock worth $202,437,000 after purchasing an additional 31,752 shares during the last quarter. Guinness Asset Management LTD boosted its holdings in shares of Aflac by 3.8% in the 3rd quarter. Guinness Asset Management LTD now owns 2,276,325 shares of the financial services provider's stock worth $254,382,000 after purchasing an additional 83,289 shares in the last quarter. ProShare Advisors LLC raised its holdings in shares of Aflac by 5.6% during the 2nd quarter. ProShare Advisors LLC now owns 2,220,125 shares of the financial services provider's stock valued at $198,279,000 after buying an additional 117,504 shares in the last quarter. Finally, Truist Financial Corp lifted its position in Aflac by 26.6% in the 2nd quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider's stock worth $172,338,000 after buying an additional 405,847 shares during the last quarter. Institutional investors own 67.44% of the company's stock.

Insider Buying and Selling at Aflac

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the company's stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the sale, the director now directly owns 18,158 shares in the company, valued at $1,796,552.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. 0.90% of the stock is currently owned by insiders.

Aflac Stock Performance

Shares of NYSE AFL traded down $0.08 during midday trading on Wednesday, hitting $109.92. 455,725 shares of the company's stock traded hands, compared to its average volume of 2,213,860. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10. The stock has a market capitalization of $62.46 billion, a price-to-earnings ratio of 12.14, a price-to-earnings-growth ratio of 2.62 and a beta of 0.95. The firm has a fifty day moving average of $110.52 and a 200 day moving average of $97.37. Aflac Incorporated has a 1 year low of $75.07 and a 1 year high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.60 by $0.23. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The firm had revenue of $5.14 billion during the quarter, compared to analysts' expectations of $4.10 billion. During the same period in the prior year, the company posted $1.58 earnings per share. The company's revenue for the quarter was down .7% compared to the same quarter last year. On average, analysts forecast that Aflac Incorporated will post 6.76 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on AFL shares. Citigroup boosted their target price on Aflac from $84.00 to $93.00 and gave the company a "neutral" rating in a research note on Tuesday, July 23rd. Evercore ISI raised their target price on shares of Aflac from $84.00 to $90.00 and gave the stock an "underperform" rating in a report on Thursday, September 26th. UBS Group upped their price target on shares of Aflac from $84.00 to $109.00 and gave the company a "neutral" rating in a report on Wednesday, August 14th. Piper Sandler boosted their price objective on shares of Aflac from $114.00 to $122.00 and gave the company an "overweight" rating in a research report on Wednesday, October 2nd. Finally, Truist Financial increased their price objective on Aflac from $82.00 to $100.00 and gave the stock a "hold" rating in a report on Friday, August 2nd. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $97.53.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.